Search jobs 17-Mar-2021 Crohn’s Disease Treatment Market Is Expected to Reach US$ 10 Billion at a 4.3% CAGR By 2025 – Coherent Market Insights
SEATTLE, March 17, 2021, (PHARMIWEB)
Crohn’s Disease Treatment Market – Insights
Crohn’s disease is a chronic inflammatory bowel disease that affects the lining of the digestive tract. Stress, diet, malfunctioning of the immune system, and heredity are some of the factors that cause Crohn’s disease. The disease is confined to the colon of the large intestine and ileum of the small intestine and can lead to life-threatening complications in some cases. Although, the condition can occur at any age, it is likely to develop at a young age. Crohn’s disease may comprise of one or more factors that include, bowel obstruction, fistulas, ulcers, anal fissures, colon cancer, and other health issues. There are no specific and dedicated tests to diagnose the Crohn’s disease and is conf
February 1, 2021
The VR exercise encouraged participants to use their senses to focus on different parts of a scene.
Getty Images
Experts are just beginning to understand how mindfulness can improve the lives of people living with chronic disease, including inflammatory bowel disease (IBD). Promising new research shows that virtual reality (VR) can be an extremely useful tool for helping kids and young adults practice mindfulness. The technology is becoming more available in children’s hospitals, and at-home headsets will expand access even more.
Researchers from Stanford University in California set out to determine how VR technology could be used to help children and young adults manage symptoms associated with IBD. They focused on short sessions centered on mindfulness and asked participants to rate their pain and anxiety before and after the session. They presented their findings at the 2020 Crohn’s and Colitis Congress.
SmartTab Publishes Groundbreaking Tech Drug Delivery Findings for the Treatment of Crohn’s Disease
Share Article Advancing High Tech Drug Delivery Systems for the Treatment of Crohn s Disease
There’s conclusive evidence that via RF signaling, the SmartTab capsule can administer active ingredients to the target sites of patients. With onboard sensors, enabling the devices to send real-time data to physicians and personalize treatments. DENVER (PRWEB) January 28, 2021
Without a cure, Crohn’s disease affects over 700,000 people in the U.S., and millions globally, according to the CDC.
The article showcases how high-tech drug delivery systems can allow for precise location targeting and efficient delivery mechanisms to reduce the risk of side effects and increase dosage effectiveness in the treatment of Crohn’s disease. SmartTab’s revolutionary capsule technology uses radio frequency (RF) signaling to t
Patients with IBD should receive COVID-19 vaccine, despite concerns Source:
Ungaro RC, et al. Understanding IBD-related Care in the Era of COVID-19. Presented at: Crohn’s and Colitis Congress (virtual); Feb. 21-24, 2021. Disclosures: Ungaro reports a financial relationship with and a commercial interest in AbbVie; receiving consulting fees for Eli Lily; receiving consulting fees and grant/research support from Bristol Myers Squibb; receiving consulting fees for and serving on the advisory committees or review panels of Pfizer, Takeda and Janssen. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on .
This article is a collaboration between MedPage Today and:
Children with inflammatory bowel disease (IBD) who develop COVID-19 generally fare quite well with the infection, having low rates of hospitalization and little mortality. That was the encouraging message from a new analysis of data from an international registry that currently includes 4,578 cases, according to Michael Kappelman, MD, of the University of North Carolina at Chapel Hill.
Of the total cases of patients with IBD and COVID-19 reported to the SECURE-IBD database, only 29 were in children under age 10. Of these, two (7%) were hospitalized (most often from the complication of multisystem inflammatory syndrome) and none died.